Scholarlink

<p>The hospital setting provides a critical environment for understanding the public health implications of antibiotic resistance, given the diversity of clinical samples and bacteria encountered. This study investigated the resistotyping and detection of ESBL and AmpC β-lactamases in clinical Gram-negative bacteria. Bacteria were obtained from the laboratory benches of a Teaching Hospital in Nigeria for three months, and identified. Antibiotic susceptibility was carried out using the disc diffusion method, while detection of ESBL production was done using the Double Disc Synergy Test (DDST). Biofilm formation by the isolates was detected using the Tissue Culture Plate method. Screening for hypermucoviscosity in <i>Klebsiella pneumoniae</i> isolates was done using the string test. Genotyping of the ESBL-producing isolates for ESBL and AmpC β-lactamases was done using primer-specific PCR. Seventy-two isolates [(<i>Klebsiella</i> (38), <i>Pseudomonas</i> (14), <i>Escherichia</i> (12), <i>Enterobacter</i> (5), <i>Hafnia</i> (1), <i>Acinetobacter</i> (1) and <i>Morganella</i> (1)] were identified. The resistance of the isolates to the antibiotics was: amoxicillin-clavulanate (69.4%), cefepime (59.7%), ceftriaxone and azithromycin (56.9% each), aztreonam 54.2%, gentamicin (52.8%), ampicillin-sulbactam (48.6%), ciprofloxacin (45.8), ceftazidime (38.9%), cefoxitin (36.1%) and cefuroxime (19.4%). Fifty-three isolates (73.6%) had multidrug-resistant phenotypes and 21 were ESBL producers. Thirty-five of the total isolates were biofilm producers, while 21.1% of the <i>Klebsiella pneumoniae</i> were hypermucoviscous. The frequency of genes in the 21 ESBL producers was <i>bla</i><sub>TEM</sub> (35.3%), <i>bla</i><sub>CTX−M</sub> (29.4%), <i>bla</i><sub>SHV</sub> (23.5%) and <i>bla</i><sub>CMY</sub> (11.8%). The occurrence of MDR and ESBL-producing bacteria from clinics raises alarm on the need to further educate people on the consequences of indiscriminate usage of antibiotics without prescription.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Antibiotic resistance profiles and co-occurrence of ESBL and AmpC β-lactamase genes in ESBL-producing Gram-negative bacteria of clinical origin

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月27日

查看全文
  • Abimbola O. Adekanmbi,
  • Lateef T. Ishola,
  • Esther B. Ogunsakin,
  • Temitope A. Ajamu,
  • Fareedah T. Lawal

摘要

The hospital setting provides a critical environment for understanding the public health implications of antibiotic resistance, given the diversity of clinical samples and bacteria encountered. This study investigated the resistotyping and detection of ESBL and AmpC β-lactamases in clinical Gram-negative bacteria. Bacteria were obtained from the laboratory benches of a Teaching Hospital in Nigeria for three months, and identified. Antibiotic susceptibility was carried out using the disc diffusion method, while detection of ESBL production was done using the Double Disc Synergy Test (DDST). Biofilm formation by the isolates was detected using the Tissue Culture Plate method. Screening for hypermucoviscosity in Klebsiella pneumoniae isolates was done using the string test. Genotyping of the ESBL-producing isolates for ESBL and AmpC β-lactamases was done using primer-specific PCR. Seventy-two isolates [(Klebsiella (38), Pseudomonas (14), Escherichia (12), Enterobacter (5), Hafnia (1), Acinetobacter (1) and Morganella (1)] were identified. The resistance of the isolates to the antibiotics was: amoxicillin-clavulanate (69.4%), cefepime (59.7%), ceftriaxone and azithromycin (56.9% each), aztreonam 54.2%, gentamicin (52.8%), ampicillin-sulbactam (48.6%), ciprofloxacin (45.8), ceftazidime (38.9%), cefoxitin (36.1%) and cefuroxime (19.4%). Fifty-three isolates (73.6%) had multidrug-resistant phenotypes and 21 were ESBL producers. Thirty-five of the total isolates were biofilm producers, while 21.1% of the Klebsiella pneumoniae were hypermucoviscous. The frequency of genes in the 21 ESBL producers was blaTEM (35.3%), blaCTX−M (29.4%), blaSHV (23.5%) and blaCMY (11.8%). The occurrence of MDR and ESBL-producing bacteria from clinics raises alarm on the need to further educate people on the consequences of indiscriminate usage of antibiotics without prescription.